

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.92284598 |
| 2 | detection of other organism (GO:0098543) | 5.57255921 |
| 3 | response to peptidoglycan (GO:0032494) | 5.57047131 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.48502197 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.48502197 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.48502197 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.48502197 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.48502197 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.48502197 |
| 10 | detection of bacterium (GO:0016045) | 5.39506194 |
| 11 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.34381864 |
| 12 | respiratory burst (GO:0045730) | 4.98716675 |
| 13 | cellular extravasation (GO:0045123) | 4.76473589 |
| 14 | lipoxygenase pathway (GO:0019372) | 4.60726219 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.60042485 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57962058 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.55764276 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46998230 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.44715427 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.31921973 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.29732096 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.28387461 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.28017362 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17576577 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 4.08383822 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07991922 |
| 27 | detection of biotic stimulus (GO:0009595) | 4.07804052 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.03725264 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.96891779 |
| 30 | granulocyte activation (GO:0036230) | 3.95801339 |
| 31 | neutrophil activation (GO:0042119) | 3.93759812 |
| 32 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.89523003 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 3.84825895 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.84104681 |
| 35 | regulation of integrin activation (GO:0033623) | 3.83676379 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.81835605 |
| 37 | lymphocyte chemotaxis (GO:0048247) | 3.80719330 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80379519 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73611187 |
| 40 | regulation of apoptotic cell clearance (GO:2000425) | 3.73357519 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.69690988 |
| 42 | leukotriene metabolic process (GO:0006691) | 3.68712930 |
| 43 | regulation of mononuclear cell migration (GO:0071675) | 3.65571367 |
| 44 | response to host immune response (GO:0052572) | 3.65266721 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.65266721 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.64994144 |
| 47 | reactive oxygen species biosynthetic process (GO:1903409) | 3.61693688 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60603998 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.60603998 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.60024265 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58873837 |
| 52 | response to interleukin-15 (GO:0070672) | 3.58029673 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.55795968 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.55482973 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.55162623 |
| 56 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.53831702 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 3.51771271 |
| 58 | superoxide anion generation (GO:0042554) | 3.51770624 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50718710 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47548600 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.44670495 |
| 62 | germinal center formation (GO:0002467) | 3.44380035 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.39756824 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.39613468 |
| 65 | positive regulation of lymphocyte migration (GO:2000403) | 3.39531181 |
| 66 | mannose metabolic process (GO:0006013) | 3.39503938 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39115342 |
| 68 | macrophage activation (GO:0042116) | 3.39059544 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.37911504 |
| 70 | regulation of T cell chemotaxis (GO:0010819) | 3.37208755 |
| 71 | positive regulation of T cell chemotaxis (GO:0010820) | 3.37208755 |
| 72 | negative regulation of cell killing (GO:0031342) | 3.36848249 |
| 73 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36848249 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 3.35914190 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 3.35005846 |
| 76 | leukocyte degranulation (GO:0043299) | 3.33913147 |
| 77 | regulation of B cell differentiation (GO:0045577) | 3.33735416 |
| 78 | B cell mediated immunity (GO:0019724) | 3.32489719 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.30510306 |
| 80 | response to host defenses (GO:0052200) | 3.28740241 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28740241 |
| 82 | response to host (GO:0075136) | 3.28740241 |
| 83 | neutrophil chemotaxis (GO:0030593) | 3.27249428 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 3.26907356 |
| 85 | apoptotic cell clearance (GO:0043277) | 3.26725944 |
| 86 | pinocytosis (GO:0006907) | 3.26709977 |
| 87 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23176368 |
| 88 | regulation of cholesterol storage (GO:0010885) | 3.22917901 |
| 89 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.22550671 |
| 90 | positive regulation of T cell migration (GO:2000406) | 3.21757050 |
| 91 | cellular response to interleukin-15 (GO:0071350) | 3.21626833 |
| 92 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.20534488 |
| 93 | negative regulation of granulocyte differentiation (GO:0030853) | 3.20141138 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.19359653 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18801754 |
| 96 | neutrophil migration (GO:1990266) | 3.17764554 |
| 97 | regulation of T cell migration (GO:2000404) | 3.16463568 |
| 98 | microglial cell activation (GO:0001774) | 3.16350176 |
| 99 | regulation of lymphocyte migration (GO:2000401) | 3.14140792 |
| 100 | regulation of regulated secretory pathway (GO:1903305) | 3.13724537 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13623222 |
| 102 | negative regulation of interleukin-6 production (GO:0032715) | 3.11190023 |
| 103 | defense response to protozoan (GO:0042832) | 3.10384286 |
| 104 | leukocyte mediated cytotoxicity (GO:0001909) | 3.10080774 |
| 105 | positive thymic T cell selection (GO:0045059) | 3.08763814 |
| 106 | leukocyte aggregation (GO:0070486) | 3.08359613 |
| 107 | activated T cell proliferation (GO:0050798) | 3.07757525 |
| 108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06873308 |
| 109 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.05976179 |
| 110 | negative thymic T cell selection (GO:0045060) | 3.04829760 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.04285105 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03959046 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03595849 |
| 114 | T cell migration (GO:0072678) | 3.03341842 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03277900 |
| 116 | positive regulation of leukocyte degranulation (GO:0043302) | 3.00610287 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98444117 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98168549 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97688566 |
| 120 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97658956 |
| 121 | granulocyte chemotaxis (GO:0071621) | 2.96432455 |
| 122 | regulation of macrophage chemotaxis (GO:0010758) | 2.96420171 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.95623367 |
| 124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.95504012 |
| 125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95155568 |
| 126 | positive regulation of interferon-beta production (GO:0032728) | 2.95114920 |
| 127 | cellular response to type I interferon (GO:0071357) | 2.94488201 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.94488201 |
| 129 | negative T cell selection (GO:0043383) | 2.94389164 |
| 130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94301504 |
| 131 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94301504 |
| 132 | positive regulation of B cell differentiation (GO:0045579) | 2.93535199 |
| 133 | negative regulation of type 2 immune response (GO:0002829) | 2.92540617 |
| 134 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92151373 |
| 135 | response to type I interferon (GO:0034340) | 2.92021291 |
| 136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92016661 |
| 137 | negative regulation of innate immune response (GO:0045824) | 2.91644956 |
| 138 | regulation of monocyte chemotaxis (GO:0090025) | 2.91245702 |
| 139 | myeloid leukocyte activation (GO:0002274) | 2.90932116 |
| 140 | positive regulation of tolerance induction (GO:0002645) | 2.90854775 |
| 141 | response to protozoan (GO:0001562) | 2.90435398 |
| 142 | tolerance induction (GO:0002507) | 2.88965819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.00690637 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.16258975 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.94783548 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.69585173 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.34496506 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77421422 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66385237 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60760250 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.53010308 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.22970737 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.97056976 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92725147 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84456284 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76343593 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.61011414 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55776232 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54884678 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.44958194 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.39226828 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31385043 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14124285 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13821406 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02437854 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.97811402 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94735064 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90151023 |
| 27 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.88147654 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83222119 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81844213 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76235318 |
| 31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73186185 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72708460 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68404773 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66857059 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66660355 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.63610450 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62462708 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60077204 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57875943 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56679358 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54665646 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53629689 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.52078090 |
| 44 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51389018 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48579443 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48093725 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47302408 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47048543 |
| 49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46446788 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39934654 |
| 51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36596468 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36568168 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35672509 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35640224 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33533054 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32857762 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32458085 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27662598 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.24736670 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19324585 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15057308 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14985232 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14176758 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13703070 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09203873 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08839711 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08122764 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07216066 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04190880 |
| 70 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03708559 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03133698 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02644145 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02536910 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02509836 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02507316 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02262769 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01606551 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01095073 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99307897 |
| 80 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97257846 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96095721 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95769501 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95085813 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94812933 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 0.94684303 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91693194 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90896091 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90794550 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90632100 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89288609 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88060464 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87177122 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87133046 |
| 94 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.85639845 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85038898 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84323995 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83546869 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82734924 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82106552 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 0.81592950 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80894507 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78228045 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76594288 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74131573 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72653648 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71820467 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71795372 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71278339 |
| 109 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69307043 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67603566 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67337128 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.64755187 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60531717 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.60120334 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.58898714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.61105896 |
| 2 | * MP0003436_decreased_susceptibility_to | 3.94330155 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.76446068 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.71649376 |
| 5 | MP0009785_altered_susceptibility_to | 3.47475411 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.47080284 |
| 7 | MP0003303_peritoneal_inflammation | 3.35062093 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.23113877 |
| 9 | * MP0005025_abnormal_response_to | 3.13868337 |
| 10 | MP0005387_immune_system_phenotype | 3.00984289 |
| 11 | MP0001790_abnormal_immune_system | 3.00984289 |
| 12 | MP0003724_increased_susceptibility_to | 2.88188760 |
| 13 | MP0006082_CNS_inflammation | 2.74802433 |
| 14 | MP0000685_abnormal_immune_system | 2.74169751 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.68591688 |
| 16 | * MP0001800_abnormal_humoral_immune | 2.54094839 |
| 17 | MP0002723_abnormal_immune_serum | 2.41958454 |
| 18 | MP0009840_abnormal_foam_cell | 2.32677595 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.30249786 |
| 20 | MP0001819_abnormal_immune_cell | 2.24844920 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.24123912 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.23728493 |
| 23 | MP0005671_abnormal_response_to | 2.22934115 |
| 24 | * MP0001533_abnormal_skeleton_physiology | 2.20138217 |
| 25 | MP0004510_myositis | 2.17256062 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.10107054 |
| 27 | MP0002405_respiratory_system_inflammati | 2.03141593 |
| 28 | MP0002132_abnormal_respiratory_system | 2.00021212 |
| 29 | MP0003075_altered_response_to | 1.97559197 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.96994026 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.96056260 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.93573695 |
| 33 | MP0001853_heart_inflammation | 1.91791532 |
| 34 | MP0000343_altered_response_to | 1.89306368 |
| 35 | MP0004947_skin_inflammation | 1.88267678 |
| 36 | MP0008469_abnormal_protein_level | 1.72444007 |
| 37 | MP0000604_amyloidosis | 1.69796744 |
| 38 | MP0009764_decreased_sensitivity_to | 1.62388048 |
| 39 | MP0000716_abnormal_immune_system | 1.61524999 |
| 40 | MP0003690_abnormal_glial_cell | 1.61024404 |
| 41 | MP0005310_abnormal_salivary_gland | 1.57790109 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.56824446 |
| 43 | MP0003448_altered_tumor_morphology | 1.56537120 |
| 44 | MP0003866_abnormal_defecation | 1.55782482 |
| 45 | MP0009278_abnormal_bone_marrow | 1.51778561 |
| 46 | MP0002398_abnormal_bone_marrow | 1.45421972 |
| 47 | MP0002006_tumorigenesis | 1.42957974 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.42381738 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.40965590 |
| 50 | MP0005166_decreased_susceptibility_to | 1.35747288 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.35744354 |
| 52 | MP0002429_abnormal_blood_cell | 1.30693113 |
| 53 | MP0005451_abnormal_body_composition | 1.26274626 |
| 54 | MP0004381_abnormal_hair_follicle | 1.26224596 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.24415605 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.22666135 |
| 57 | MP0002722_abnormal_immune_system | 1.22031766 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.21042450 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.21042450 |
| 60 | MP0000858_altered_metastatic_potential | 1.19980364 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.19959564 |
| 62 | MP0001851_eye_inflammation | 1.19321983 |
| 63 | * MP0009763_increased_sensitivity_to | 1.10501012 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.10344337 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.09431222 |
| 66 | MP0002933_joint_inflammation | 1.06015379 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.04765035 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.02875504 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.02850069 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.01250939 |
| 71 | * MP0005390_skeleton_phenotype | 1.01147875 |
| 72 | MP0003828_pulmonary_edema | 1.00498521 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.99469581 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.98578931 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.98208444 |
| 76 | MP0010307_abnormal_tumor_latency | 0.97897394 |
| 77 | MP0000249_abnormal_blood_vessel | 0.95302284 |
| 78 | MP0005164_abnormal_response_to | 0.91164350 |
| 79 | MP0003186_abnormal_redox_activity | 0.88943716 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.88454704 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.88208456 |
| 82 | MP0005083_abnormal_biliary_tract | 0.86562348 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.83199436 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.79849253 |
| 85 | MP0008260_abnormal_autophagy | 0.77945790 |
| 86 | MP0004883_abnormal_blood_vessel | 0.76961997 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.73784728 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.72857913 |
| 89 | MP0002254_reproductive_system_inflammat | 0.72012485 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.70266341 |
| 91 | MP0003045_fibrosis | 0.69700934 |
| 92 | MP0000490_abnormal_crypts_of | 0.69047225 |
| 93 | MP0000609_abnormal_liver_physiology | 0.68945081 |
| 94 | MP0008004_abnormal_stomach_pH | 0.68615854 |
| 95 | MP0002009_preneoplasia | 0.68035786 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.67374742 |
| 97 | MP0003795_abnormal_bone_structure | 0.65465792 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.65215034 |
| 99 | MP0000371_diluted_coat_color | 0.63012115 |
| 100 | MP0008874_decreased_physiological_sensi | 0.61411156 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.60599176 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.59883876 |
| 103 | MP0005023_abnormal_wound_healing | 0.59821697 |
| 104 | MP0003195_calcinosis | 0.59655862 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.59638534 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.59461881 |
| 107 | MP0004130_abnormal_muscle_cell | 0.58355688 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.57360400 |
| 109 | MP0002928_abnormal_bile_duct | 0.57189217 |
| 110 | MP0008873_increased_physiological_sensi | 0.56799328 |
| 111 | MP0000920_abnormal_myelination | 0.56629955 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.56609053 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56186482 |
| 114 | MP0001915_intracranial_hemorrhage | 0.55952741 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.54967534 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54027822 |
| 117 | MP0001873_stomach_inflammation | 0.53655653 |
| 118 | MP0001663_abnormal_digestive_system | 0.53430851 |
| 119 | MP0000598_abnormal_liver_morphology | 0.51987737 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.51896599 |
| 121 | MP0005388_respiratory_system_phenotype | 0.48338323 |
| 122 | MP0002133_abnormal_respiratory_system | 0.48338323 |
| 123 | MP0005535_abnormal_body_temperature | 0.46219906 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.45824948 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.45734440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.35254714 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.71064997 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.81589498 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.74057366 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.69050311 |
| 6 | Glomerulonephritis (HP:0000099) | 5.66601035 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.39773302 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.65215334 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.38173984 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.31120646 |
| 11 | Complement deficiency (HP:0004431) | 4.22162566 |
| 12 | Gingivitis (HP:0000230) | 4.22077255 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.18269271 |
| 14 | Recurrent skin infections (HP:0001581) | 4.13219584 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12147153 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.95345422 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.89363084 |
| 18 | Obstructive lung disease (HP:0006536) | 3.79222129 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79222129 |
| 20 | Encephalitis (HP:0002383) | 3.78028188 |
| 21 | Pustule (HP:0200039) | 3.60757463 |
| 22 | Increased IgE level (HP:0003212) | 3.54450817 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.50784922 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.50784922 |
| 25 | Nephritis (HP:0000123) | 3.50505348 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.48731625 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.45824260 |
| 28 | Myositis (HP:0100614) | 3.44314723 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44235476 |
| 30 | Hypochromic anemia (HP:0001931) | 3.39235086 |
| 31 | * Abnormality of complement system (HP:0005339) | 3.38335643 |
| 32 | Disinhibition (HP:0000734) | 3.36156754 |
| 33 | Episodic fever (HP:0001954) | 3.35828391 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.34921891 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.34921891 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.34921891 |
| 37 | Chest pain (HP:0100749) | 3.32110183 |
| 38 | Periodontitis (HP:0000704) | 3.27267526 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.26859403 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.26859403 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.26859403 |
| 42 | Orchitis (HP:0100796) | 3.24852128 |
| 43 | Amyloidosis (HP:0011034) | 3.19355272 |
| 44 | Cellulitis (HP:0100658) | 3.12886402 |
| 45 | Axonal loss (HP:0003447) | 3.12336632 |
| 46 | Stomatitis (HP:0010280) | 3.12106295 |
| 47 | Recurrent viral infections (HP:0004429) | 2.96786185 |
| 48 | Joint hemorrhage (HP:0005261) | 2.96464882 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.95286490 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.89706026 |
| 51 | Optic neuritis (HP:0100653) | 2.87280503 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.87280503 |
| 53 | Prostate neoplasm (HP:0100787) | 2.85770727 |
| 54 | Loss of speech (HP:0002371) | 2.83283507 |
| 55 | Thick nail (HP:0001805) | 2.80350345 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.77351026 |
| 57 | Urticaria (HP:0001025) | 2.76503671 |
| 58 | Anorexia (HP:0002039) | 2.76418294 |
| 59 | T lymphocytopenia (HP:0005403) | 2.76237094 |
| 60 | Vasculitis (HP:0002633) | 2.70371007 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.69244441 |
| 62 | Pulmonary embolism (HP:0002204) | 2.68955508 |
| 63 | Meningitis (HP:0001287) | 2.68108850 |
| 64 | Agnosia (HP:0010524) | 2.65246120 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.63109257 |
| 66 | Petechiae (HP:0000967) | 2.63055907 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.61227689 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.57876373 |
| 69 | Abnormality of T cells (HP:0002843) | 2.53951572 |
| 70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53461212 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53461212 |
| 72 | Increased IgM level (HP:0003496) | 2.51510566 |
| 73 | Granulocytopenia (HP:0001913) | 2.50928894 |
| 74 | Microcytic anemia (HP:0001935) | 2.46375878 |
| 75 | Basal ganglia calcification (HP:0002135) | 2.44710135 |
| 76 | Myocardial infarction (HP:0001658) | 2.41738739 |
| 77 | Gangrene (HP:0100758) | 2.39946444 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.39174434 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.38709859 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.38473326 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38307415 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.36019080 |
| 83 | Sepsis (HP:0100806) | 2.34645260 |
| 84 | Osteomyelitis (HP:0002754) | 2.33310255 |
| 85 | Abnormality of the lumbar spine (HP:0100712) | 2.32728104 |
| 86 | Gingival bleeding (HP:0000225) | 2.32207466 |
| 87 | Lymphopenia (HP:0001888) | 2.29993211 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 2.29723875 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.29560824 |
| 90 | Arterial thrombosis (HP:0004420) | 2.25887700 |
| 91 | Chronic otitis media (HP:0000389) | 2.24847902 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.24839068 |
| 93 | Pathologic fracture (HP:0002756) | 2.24706172 |
| 94 | Poor head control (HP:0002421) | 2.24277558 |
| 95 | Increased serum ferritin (HP:0003281) | 2.23084112 |
| 96 | Upper motor neuron abnormality (HP:0002127) | 2.21407787 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.20991449 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19535471 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 2.19535471 |
| 100 | Peritonitis (HP:0002586) | 2.17297139 |
| 101 | Leukocytosis (HP:0001974) | 2.16159903 |
| 102 | Colitis (HP:0002583) | 2.15828584 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 2.14355290 |
| 104 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13455783 |
| 105 | Thoracic kyphosis (HP:0002942) | 2.11440974 |
| 106 | Purpura (HP:0000979) | 2.10780654 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09415290 |
| 108 | Vertigo (HP:0002321) | 2.09203039 |
| 109 | Glomerulopathy (HP:0100820) | 2.09077622 |
| 110 | Epistaxis (HP:0000421) | 2.07392181 |
| 111 | Agammaglobulinemia (HP:0004432) | 2.06933609 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 2.06731513 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06198200 |
| 114 | Asymmetric septal hypertrophy (HP:0001670) | 2.05458441 |
| 115 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.03881535 |
| 116 | Eosinophilia (HP:0001880) | 2.03159292 |
| 117 | Nasal polyposis (HP:0100582) | 2.02784332 |
| 118 | Abnormality of the endocardium (HP:0004306) | 2.02617484 |
| 119 | Spondylolisthesis (HP:0003302) | 2.01951595 |
| 120 | Keratitis (HP:0000491) | 2.01817531 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.99978066 |
| 122 | Prolonged bleeding time (HP:0003010) | 1.99018215 |
| 123 | Abnormality of the pericardium (HP:0001697) | 1.98043720 |
| 124 | Acne (HP:0001061) | 1.97208377 |
| 125 | Acute hepatic failure (HP:0006554) | 1.94648104 |
| 126 | Diminished motivation (HP:0000745) | 1.94119297 |
| 127 | Polyneuropathy (HP:0001271) | 1.93313370 |
| 128 | IgM deficiency (HP:0002850) | 1.92483527 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91790615 |
| 130 | Deformed sella turcica (HP:0002681) | 1.91742061 |
| 131 | Hematochezia (HP:0002573) | 1.91714866 |
| 132 | Apathy (HP:0000741) | 1.90875514 |
| 133 | Menorrhagia (HP:0000132) | 1.89670100 |
| 134 | Viral hepatitis (HP:0006562) | 1.88560796 |
| 135 | Skin rash (HP:0000988) | 1.87885566 |
| 136 | Amaurosis fugax (HP:0100576) | 1.87374238 |
| 137 | Premature loss of primary teeth (HP:0006323) | 1.83995248 |
| 138 | Gastrointestinal inflammation (HP:0004386) | 1.83445096 |
| 139 | Keratoconjunctivitis sicca (HP:0001097) | 1.83431277 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.82704648 |
| 141 | Slow saccadic eye movements (HP:0000514) | 1.81477901 |
| 142 | Bone pain (HP:0002653) | 1.81400743 |
| 143 | Polycythemia (HP:0001901) | 1.80658843 |
| 144 | Hypergammaglobulinemia (HP:0010702) | 1.80566645 |
| 145 | Hemoptysis (HP:0002105) | 1.80508062 |
| 146 | Skin ulcer (HP:0200042) | 1.80481733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.84291748 |
| 2 | RIPK4 | 3.94925832 |
| 3 | IRAK4 | 3.68039782 |
| 4 | MAP4K1 | 3.28542977 |
| 5 | MAP3K14 | 3.24723756 |
| 6 | TYK2 | 2.83099053 |
| 7 | ERN1 | 2.75202738 |
| 8 | TBK1 | 2.71669111 |
| 9 | TNK2 | 2.59677240 |
| 10 | PRPF4B | 2.36742779 |
| 11 | MST1R | 2.25748160 |
| 12 | KIT | 2.15750368 |
| 13 | IRAK3 | 2.02963521 |
| 14 | TAOK1 | 1.90663030 |
| 15 | IKBKB | 1.87345245 |
| 16 | TAOK3 | 1.81382597 |
| 17 | TXK | 1.77119451 |
| 18 | BTK | 1.76948151 |
| 19 | CSK | 1.70045345 |
| 20 | FES | 1.69496842 |
| 21 | PBK | 1.68115577 |
| 22 | ZAP70 | 1.65107781 |
| 23 | IKBKE | 1.64906370 |
| 24 | JAK1 | 1.64036236 |
| 25 | HCK | 1.63252332 |
| 26 | SYK | 1.61252150 |
| 27 | CSF1R | 1.60535400 |
| 28 | EPHB1 | 1.59294516 |
| 29 | JAK3 | 1.58844375 |
| 30 | TEC | 1.54386495 |
| 31 | SIK3 | 1.50345860 |
| 32 | NEK9 | 1.50187144 |
| 33 | MAP3K13 | 1.39126620 |
| 34 | CAMK1D | 1.38712123 |
| 35 | FGR | 1.37845224 |
| 36 | LYN | 1.36741193 |
| 37 | TGFBR2 | 1.32273103 |
| 38 | PIM2 | 1.28416173 |
| 39 | MAP2K3 | 1.28271944 |
| 40 | BMX | 1.28080340 |
| 41 | CDK19 | 1.21697683 |
| 42 | STK10 | 1.21341924 |
| 43 | TRIB3 | 1.20007688 |
| 44 | CLK1 | 1.12754144 |
| 45 | LCK | 1.11701533 |
| 46 | JAK2 | 1.10056955 |
| 47 | KSR2 | 1.09503516 |
| 48 | MARK2 | 1.05294801 |
| 49 | GRK6 | 1.03331614 |
| 50 | RIPK1 | 1.02370262 |
| 51 | MAP3K11 | 0.98895169 |
| 52 | CHUK | 0.98312356 |
| 53 | TAOK2 | 0.97284455 |
| 54 | NME2 | 0.96788015 |
| 55 | BMPR2 | 0.95430544 |
| 56 | PRKD2 | 0.93786259 |
| 57 | PDK1 | 0.93279820 |
| 58 | MATK | 0.92213530 |
| 59 | ABL2 | 0.87130505 |
| 60 | PIM1 | 0.86904065 |
| 61 | GRK7 | 0.86749132 |
| 62 | PKN2 | 0.82176426 |
| 63 | RPS6KA4 | 0.81590363 |
| 64 | IRAK2 | 0.81249799 |
| 65 | CAMKK2 | 0.81119529 |
| 66 | MARK3 | 0.80392758 |
| 67 | ITK | 0.77450544 |
| 68 | PRKCD | 0.76437809 |
| 69 | DAPK2 | 0.74421989 |
| 70 | MAP3K7 | 0.74056689 |
| 71 | LRRK2 | 0.73839150 |
| 72 | CAMK1G | 0.73628403 |
| 73 | MAP3K6 | 0.73404508 |
| 74 | STK4 | 0.70774400 |
| 75 | TESK2 | 0.69170496 |
| 76 | YES1 | 0.66975023 |
| 77 | MAPK12 | 0.64861825 |
| 78 | MAPK7 | 0.64830216 |
| 79 | TTN | 0.64551919 |
| 80 | CAMKK1 | 0.64173664 |
| 81 | PTK2B | 0.63433333 |
| 82 | SIK2 | 0.62133063 |
| 83 | TRPM7 | 0.62102214 |
| 84 | EGFR | 0.60355973 |
| 85 | STK11 | 0.59872461 |
| 86 | HIPK2 | 0.58265295 |
| 87 | DYRK1B | 0.57308233 |
| 88 | ABL1 | 0.56903207 |
| 89 | MAP2K4 | 0.56667704 |
| 90 | SMG1 | 0.56432401 |
| 91 | EPHA3 | 0.52407039 |
| 92 | MAP3K2 | 0.52066954 |
| 93 | SGK3 | 0.49830595 |
| 94 | MAP3K5 | 0.47748126 |
| 95 | CDC42BPA | 0.46666136 |
| 96 | MAP3K3 | 0.45613347 |
| 97 | PTK6 | 0.45291520 |
| 98 | MST4 | 0.43906347 |
| 99 | FYN | 0.43324838 |
| 100 | CDK6 | 0.42389637 |
| 101 | FGFR4 | 0.42186448 |
| 102 | ADRBK2 | 0.42172003 |
| 103 | FGFR3 | 0.42143222 |
| 104 | MAPKAPK2 | 0.40732408 |
| 105 | RPS6KA6 | 0.40626627 |
| 106 | DAPK1 | 0.40193626 |
| 107 | SIK1 | 0.39868250 |
| 108 | PRKCQ | 0.39494190 |
| 109 | PRKCH | 0.39433759 |
| 110 | IGF1R | 0.39242648 |
| 111 | EIF2AK2 | 0.39122973 |
| 112 | DAPK3 | 0.38632843 |
| 113 | STK38 | 0.37933609 |
| 114 | MET | 0.37423825 |
| 115 | MAP3K1 | 0.36042038 |
| 116 | IRAK1 | 0.35872183 |
| 117 | PIK3CG | 0.34911299 |
| 118 | SCYL2 | 0.34491610 |
| 119 | RAF1 | 0.34008097 |
| 120 | MOS | 0.33764551 |
| 121 | RET | 0.33649952 |
| 122 | ERBB3 | 0.33173951 |
| 123 | PAK4 | 0.32280527 |
| 124 | NLK | 0.31872321 |
| 125 | KSR1 | 0.31632638 |
| 126 | MAP3K10 | 0.30724931 |
| 127 | MAP3K12 | 0.30587310 |
| 128 | RPS6KC1 | 0.30110986 |
| 129 | RPS6KL1 | 0.30110986 |
| 130 | PRKG2 | 0.29940943 |
| 131 | SGK2 | 0.28785488 |
| 132 | MAP2K6 | 0.28582697 |
| 133 | FLT3 | 0.28090300 |
| 134 | RPS6KA2 | 0.27314442 |
| 135 | PRKCZ | 0.27052799 |
| 136 | PDPK1 | 0.26560364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.85501184 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53351066 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.17607420 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 3.01849743 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.86194536 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.58631147 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53322802 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.49147698 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44665789 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36275481 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31318629 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.30315789 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.24677426 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07438377 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.92035085 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84570552 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80396106 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75647369 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74001497 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.70623843 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66254825 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.64647490 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64197906 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.60967446 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55627164 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54662775 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48820284 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44559296 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42817703 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.39872271 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.39755970 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38618910 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31084216 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.30441740 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30337078 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27338511 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26749040 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22167743 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.20816499 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.11521656 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11433610 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10207806 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06691311 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05908477 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05885687 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01103672 |
| 47 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.00003950 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.96853057 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96845588 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95078109 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93633662 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82983090 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80793307 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80609649 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.75203376 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73392899 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72683013 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71194455 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70292511 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69266614 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68814037 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.67944365 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.66356759 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64861731 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64511687 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60102376 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58322442 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57353218 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56549520 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56395441 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56066873 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55509311 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54052396 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53800152 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52186892 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50964578 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50421300 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50354343 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48908934 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48139694 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47874583 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47467485 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45181387 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44575894 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44356685 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43643685 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42326916 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42224424 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41815301 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41804923 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41517855 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38353012 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38323599 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37943127 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37487290 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.36859487 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34946988 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33713603 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33499686 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30907773 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30629760 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.28914057 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27501558 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26820095 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26310383 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25233822 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25229343 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.25099079 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21914763 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.21180194 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21146357 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19511146 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19215172 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18388475 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.18005475 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16280379 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13875954 |
| 118 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.13391718 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11613231 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.11283216 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11170057 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10471332 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.10420243 |

